nmn

NMN (nicotinamide mononucleotide, also written beta-NMN) is a niacin-like compound that cells can use along the NAD pathway. NAD (nicotinamide adenine dinucleotide) is a coenzyme the body relies on for energy-related metabolism and for processes such as maintaining genome integrity (often summarized as DNA repair). The NIH Office of Dietary Supplements lists NMN among niacin-related compounds (niacin is vitamin B3) that are sold as dietary supplements but are not marketed or labeled as a source of niacin.

High-quality human evidence that NMN improves health or slows aging is limited and not established; it is sold and discussed mainly on the basis of its role in NAD metabolism and early-stage research rather than proven clinical benefits. The cited NIH Office of Dietary Supplements niacin fact sheet does not document health benefits for NMN; it only identifies NMN as a niacin-like compound sold as a supplement and addresses its regulatory status. Claims that NMN slows aging, boosts performance, or treats or prevents any disease are not supported by that source and should be treated as unproven. Regulatory status note: in November 2022 the FDA took the position that NMN could not be lawfully marketed as a dietary supplement because it had earlier been authorized for investigation as a new drug, and the cited NIH niacin fact sheet reflects that 2022 position. That status has since been contested and revised, so the current US regulatory status of NMN may differ from what older references state; verify the latest FDA position before relying on it.

There is no established or officially recommended dose of NMN, and the NIH does not set a recommended intake or a tolerable upper limit specifically for NMN. Any specific milligram amounts circulating online come from small studies or product marketing, not from an endorsed regimen, and the cited NIH source does not specify an NMN dose. Because NMN's US regulatory status has been unsettled and its long-term safety is not established, talk to a qualified clinician before using it, particularly if you take medications, are pregnant or breastfeeding, or have a health condition.

Long-term safety of NMN in humans has not been established, and the cited NIH source does not characterize its safety profile. NMN is chemically distinct from nicotinic acid, the form of niacin associated with flushing and, at very high chronic doses, liver concerns; however, that does not mean NMN has been shown to be safe, and its own safety over months to years is not well characterized. Pregnant or breastfeeding people, children, and anyone with a medical condition should avoid NMN unless a clinician specifically advises otherwise.

The side-effect profile of NMN is not well characterized, and the cited NIH source does not describe side effects for it. Reports from a few small, short studies have generally described it as tolerable, but those trials were limited in size and duration, so the full range of possible side effects, especially with long-term use, remains unknown. Stop use and seek medical advice if you experience an adverse reaction.

Drug and supplement interactions for NMN have not been well studied and cannot be ruled out; the cited NIH source does not list interactions specific to NMN. Because NMN relates to NAD and B-vitamin metabolism, anyone taking prescription medications, or other niacin or NAD-precursor supplements, should check with a clinician or pharmacist before combining them.